Compared with control group, lung samples originating from RA-ILD patients exhibited increased LTBP2 expression, while co-immunostaining of α-SMA suggested that LTBP2 was co-localized in activated fibroblasts/myofibroblasts (Figure 9A). The gene discussed is LTBP2; the disease is interstitial lung disease.